Pitt team IDs two new and very large classes of RNAs linked to cancer biomark
2015-05-26
(Press-News.org) PITTSBURGH, May 26, 2015 - Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer. Their findings were published in the June issue of the scientific journal RNA.
Levels of human Y-box binding protein 1 (YB-1), which is involved in many cellular functions, have been shown to correlate with drug resistance and poor patient outcomes in a variety of cancers. The observation that this cancer biomarker is tightly linked to a surprisingly large and diverse class of RNAs, and the known associations of some of these RNAs to cancer opens an opportunity to discover a potentially very important pathway in human biology and cancer, said senior investigator Bino John, Ph.D., adjunct professor, Pitt School of Medicine, where the research was conducted.
Intriguingly, one of the abundant RNAs that the team discovered was found to originate from the widely known DNA region of the Dicer1 gene and was determined to control multiple genes involved in cancer progression.
"Many small RNAs known as microRNAs already have been shown to correlate with different grades of prostate cancer and could potentially serve as biomarkers for diagnosis and treatment," Dr. John said. "We did this study after computer models led us to hypothesize that there was a connection between YB-1 and microRNAs. What started out as a curiosity-driven experiment ended up being an exhilarating treasure hunt over four years, culminating in the discovery of two big molecular finds from human cells."
The Pitt scientists discovered that YB-1 associated with many microRNAs, and were surprised by the realization that YB-1 associated with thousands of RNAs that were never before known. The team grouped the RNAs into what they called YB-1 associated short non-coding RNAs, or shyRNAs, and their smaller, processed counterparts, dubbed YB-1 associated small RNAs (smyRNAs).
"We conducted functional assays on one of these RNAs, and found that it had the ability to suppress cancer cell growth when it interacted with YB-1," said co-senior author Donald B. DeFranco, Ph.D., professor of pharmacology and chemical biology, Pitt School of Medicine. "More work must be done to determine how these shyRNAs interact to influence cancer progression and perhaps influence other diseases."
INFORMATION:
The team included Teresa T. Liu, Ph.D., Gustavo Arango-Argoty, Zhihua Li, Ph.D., Yuefeng Lin, Sang Woo Kim, Ph.D., and A. Paula Monaghan, Ph.D., all of Pitt at the time of the study; Anne Dueck, Ph.D., and Gunter Meister, Ph.D., of the University of Regensburg; and Fatih Ozsolak, Ph.D., of Helicos Biosciences.
The research was supported by the Mathers Foundation; National Institutes of Health grant GM079756; American Cancer Society; Deutsche Forschungsgemeinschaft; the European Research Council; and the Bavarian Genome Research Network.
About the University of Pittsburgh School of Medicine
As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see http://www.medschool.pitt.edu.
http://www.upmc.com/media
Contact: Anita Srikameswaran
Phone: 412-720-2058
E-mail: SrikamAV@upmc.edu
Contact: Allison Hydzik
Phone: 412-647-9975
E-mail: HydzikAM@upmc.edu
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-26
When Walt Disney created Mickey Mouse, he didn't give much thought to how he might bring his character to life in the real world. But robotics now puts that possibility within reach, so Disney researchers have found a way for a robot to mimic an animated character's walk.
Beginning with an animation of a diminutive, peanut-shaped character that walks with a rolling, somewhat bow-legged gait, Katsu Yamane and his team at Disney Research Pittsburgh analyzed the character's motion to design a robotic frame that could duplicate the walking motion using 3D-printed links and ...
2015-05-26
College Park, Md and Annapolis, Md -- A new study from researchers at the University of Maryland (UMD) and the National Socio-Environmental Synthesis Center (SESYNC) demonstrates that the highly contentious debate on climate change is fueled in part by how information flows throughout policy networks.
The UMD and SESYNC researchers found that "echo chambers"--social network structures in which individuals with the same viewpoint share information with each other--play a significant role in climate policy communication. The researchers say that echo chambers may help ...
2015-05-26
Ask any molecular plant biologist about RNA extractions and you might just open up the floodgates to the woes of troubleshooting. RNA extraction is a notoriously tricky and sensitive lab procedure. New protocols out of the University of Florida are quicker, more effective, and more reliable than previous methods.
"Obtaining pure and intact RNA samples is essential for sequencing the active genes, or the transcriptome, of a plant," explains botanist Ingrid Jordon-Thaden, who developed the protocols.
The protocols are given in bench-ready form with detailed notes and ...
2015-05-26
Adam C. Levine, M.D., an emergency medicine physician at Rhode Island Hospital found that the World Health Organization's current weight-based guidelines for assessing malnutrition in children with diarrhea are not as reliable as measuring the child's upper arm circumference. His research was published in the Journal of Nutrition.
Diarrhea is common among children who visit health facilities in developing nations. The traditional measures for determining whether a child is moderately or severely malnourished are based on assessing the child's weight directly. Levine found ...
2015-05-26
Old-school field work meets cutting-edge technology! For decades, researchers have been making artificial eggs out of plaster, wood, and other materials to test how birds identify and reject the eggs that invading "brood parasites" sometimes sneak into their nests. But these methods have many limitations, and a new study published in the open-access journal PeerJ is the first to test the usefulness of 3D printed eggs for research on egg rejection.
Brood parasites are birds that don't build nests of their own. Instead, they slip their eggs into the nests of other species, ...
2015-05-26
Scientists at the Molecular Medicine Institute in Lisbon, Portugal, and at the University College London Ear Institute, United Kingdom, have developed a simple and efficient protocol to generate inner ear hair cells, the cells responsible for our hearing and sense of balance. This study is an important step for the future production of large numbers of these cells for use in cell transplantation therapies or large-scale drug screens. The research has just been published in the scientific journal Development at http://dev.biologists.org/.
Sensory hair cells located in ...
2015-05-26
COLUMBUS, Ohio - If you're watching television while using a second screen - like a smartphone or tablet - new research suggests that some of the most expensive marketing messages aimed at you are missing their mark.
While the trend of "second screen" use has become pervasive, this is the first study to show that viewers have trouble recalling brands they see (or hear) on TV if they're using such devices.
"Viewers don't even remember that your brand was there on TV because they were busy posting on Facebook or Twitter or reading email," said Jonathan Jensen, who led ...
2015-05-26
Irvine, Calif., May 26, 2015 - The Millennium Drought in southeastern Australia forced Greater Melbourne, a city of 4.3 million people, to successfully implement innovations that hold critical lessons for water-stressed regions around the world, according to findings by UC Irvine and Australian researchers.
It wasn't a new pipeline over the mountains, special rate hikes or a $6 billion desalination plant that kept faucets running. Rather, integrated outreach by utilities and agencies required to work together led to a culture shift among ordinary water users, according ...
2015-05-26
CHARLOTTESVILLE, VA (MAY 26, 2015). A surgical skills laboratory and corresponding dissection curricula were established in the Department of Neurosurgery at the Cleveland Clinic in the 2011-2012 academic year. The authors describe how this came about and what it has meant for neurosurgical resident training and assessment of residents' surgical skills in the following paper: "Establishing a surgical skills laboratory and dissection curriculum for neurosurgical residency training" by James K. C. Liu, MD, and colleagues, published today online, ahead of print in the Journal ...
2015-05-26
A new study has shed light on how cancer patients' attitudes and beliefs drive the use of complementary and alternative medicine. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help hospitals develop more effective and accessible integrative oncology services for patients.
Although many cancer patients use complementary and alternative medicine, what drives this usage is unclear. To investigate, a team led by Jun Mao, MD and Joshua Bauml, MD, of the Abramson Cancer Center at the University of Pennsylvania's Perelman ...
LAST 30 PRESS RELEASES:
[Press-News.org] Pitt team IDs two new and very large classes of RNAs linked to cancer biomark
